NASDAQ: CELC - Celcuity Inc.

छह महीने के लिए लाभप्रदता: -33.75%
भाग प्रतिफल: 0.00%
सेक्टर: Healthcare

पदोन्नति कार्यक्रम Celcuity Inc.

उन्नत शेड्यूल सरल ग्राफ
Financial Markets by TradingView

कंपनी के बारे में Celcuity Inc.

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment.

अधिक जानकारी
Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, and advanced or metastatic breast cancer. The company is also developing CELsignia MP test, a qualitative laboratory developed test that measures HER2, c-Met, and PI3K signaling activity in breast and ovarian tumor cells. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. The company was founded in 2011 and is headquartered in Minneapolis, Minnesota.
तुलना सूची में जोड़ें
घड़ी सूची में जोड़ें
पोर्टफोलियो में जोड़ें
मूल्य सूचना जोड़ें

IPO date 2017-09-20
ISIN US15102K1007
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.celcuity.com
Цена ао 10.03
प्रति दिन मूल्य परिवर्तन: 0% (10.03)
प्रति सप्ताह मूल्य परिवर्तन: -5.73% (10.64)
प्रति माह मूल्य परिवर्तन: -19.18% (12.41)
3 महीने में कीमत में बदलाव: -19.89% (12.52)
छह महीने में कीमत में बदलाव: -33.75% (15.14)
प्रति वर्ष मूल्य परिवर्तन: -43.68% (17.81)
3 वर्षों में मूल्य परिवर्तन: +6.14% (9.45)
5 वर्षों में मूल्य परिवर्तन: -2.62% (10.3)
वर्ष की शुरुआत से मूल्य परिवर्तन: -16.42% (12)
सभी पैरामीटर

बहुत मूल्यवान समझना

नाम अर्थ श्रेणी
P/S 0 0
P/BV 2.54 6
P/E 0 0
EV/EBITDA -5.47 0
कुल: 3

क्षमता

नाम अर्थ श्रेणी
ROA, % -33.35 0
ROE, % -45.63 0
कुल: 0

लाभांश

नाम अर्थ श्रेणी
Div yield, % 0 0
DSI 0 0
कुल: 0

कर्तव्य

नाम अर्थ श्रेणी
Debt/EBITDA -0.5632 10
कुल: 8

विकास का आवेग

नाम अर्थ श्रेणी
लाभप्रदता Revenue, % 0 0
लाभप्रदता Ebitda, % 687.97 10
लाभप्रदता EPS, % 292.34 10
कुल: 8
अधिक जानकारी

संस्थानों आयतन शेयर करना, %
Morgan Stanley 2195179 7.21
Soleus Capital Management, L.P. 2179481 7.16
VR Adviser, LLC 1885538 6.19
COMMODORE CAPITAL LP 1754704 5.76
Perceptive Advisors LLC 1481300 4.86
NEA Management Company, LLC 1250001 4.1
Blackrock Inc. 1050391 3.45
Vanguard Group Inc 820776 2.7
CapTrust Financial Advisors 544835 1.79
Baker Brothers Advisors, LLC 535478 1.76

ETFशेयर करना, %वर्ष के लिए लाभप्रदता, %लाभांश, %
Jacob Forward ETF 0.85997 43.03 0.15284
Virtus LifeSci Biotech Clinical Trials ETF 0.76638 63.04 0.33
iShares Micro-Cap ETF 0.1014 17.09 1.54048
Vanguard Russell 2000 Growth ETF 0.03 23.05 0.60264
iShares Russell 2000 Growth ETF 0.02744 38.04 0.6026
Vanguard Russell 2000 ETF 0.01 17.16 1.48801
iShares Morningstar Small-Cap Growth ETF 0.00891 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.00891 587.89 0.72598
ProShares UltraPro Russell2000 0.0075 89.82 1.47873
iShares Morningstar Small-Cap ETF 0.00435 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.00435 391.25 1.60498
Humankind US Stock ETF 0.00221 18.81 1.99919
ProShares Hedge Replication ETF 0.00212 5.92 1.47892
iShares Russell 3000 ETF 0.00079 24.83 1.43482
Vanguard Russell 3000 ETF 0 31.87 1.43817
0.1294.371.15



पर्यवेक्षक नौकरी का शीर्षक भुगतान जन्म का साल
Mr. Brian F. Sullivan Co-Founder, Chairman & CEO 478.12k 1962 (63 वर्ष)
Dr. Lance G. Laing Ph.D. Co-Founder, Chief Science Officer, VP, Secretary & Director 389.55k 1962 (63 वर्ष)
Ms. Vicky Hahne Chief Financial Officer 281.59k 1966 (59 साल)
Dr. John R. MacDonald Dabt, Ph., Ph.D. Senior Vice President of R&D N/A 1955 (70 साल)
Ms. Sheri Smith Acting Head of Clinical Operations N/A
Mr. Igor Gorbatchevsky M.D. Chief Medical Officer N/A
Mr. Eldon C. Mayer III, M.B.A. Chief Commercial Officer N/A 1961 (64 वर्ष)
Dr. Charlotte Moser M.B.A., M.D., M.Sc., Ph.D. Senior Vice President of Clinical Development

पता: United States, Minneapolis. MN, 16305–36th Avenue North - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://www.celcuity.com